309
Participants
Start Date
May 19, 2016
Primary Completion Date
February 16, 2018
Study Completion Date
December 31, 2026
Ramucirumab
Administered IV
Merestinib
Administered orally
Cisplatin
Administered IV
Gemcitabine
Administered IV
Placebo Oral
Administered orally
Placebo IV
Administered IV
National Cheng-Kung Uni. Hosp., Tainan City
KH der Barmherzigen Brüder Wien, Vienna
Fundacion Favaloro, Ciudad de Buenos Aires
Del-pesti Centrumkorhaz - Orszagos Hematologiai es Infektologiai Intezet, Budapest
Cliniques universitaires Saint-Luc, Brussels
Baskent University Dr. Turgut Noyan Research and Training Center, Adana
Alexander Fleming, CABA
Calvary Mater Newcastle, Waratah
Landesklinikum Wr. Neustadt, Wiener Neustadt
Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg, Leuven
Austin Health, Heidelberg
Centro Medico San Roque, San Miguel de Tucumán
Debreceni Egyetem Klinikai Kozpont Onkologiai Tanszek, Debrecen
Royal Adelaide Hospital, Adelaide
Odense Universitetshospital, Odense C
Universitätsklinikum Salzburg, Salzburg
Aarhus Universitetshospital, Aarhus Sygehus, Aarhus C
Universitair Ziekenhuis Gent, Ghent
Taipei Veterans General Hospital, Taipei
HELIOS Klinikum Berlin-Buch, Berlin
Karolinska Universitetssjukhuset i Solna, Stockholm
Thomas Jefferson University, Philadelphia
Georgetown University Medical Center, Washington D.C.
Universitaetsklinikum Hamburg-Eppendorf, Hamburg
Skåne universitetssjukhus, Malmo
Trakya University, Edirne
CHU de Besancon Hopital Jean Minjoz, Besançon
Hospital General Universitario Gregorio Marañon, Madrid
Hospital Clinico de San Carlos, Madrid
Hospital Universitario 12 de Octubre, Madrid
Medizinische Hochschule Hanover, Hanover
University of Florida School of Medicine, Gainesville
CHU de Bordeaux Hop St ANDRE, Bordeaux
Chang Gung Memorial Hospital - Linkou, Taoyuan
Istanbul Universitesi-Cerrahpasa Cerrahpasa Tip Fakultesi Yerleskesi, Istanbul
CHRU de Montpellier-Hopital St Eloi, Montpellier
Florida Cancer Specialists, Nashville
Tennessee Oncology PLLC, Nashville
China Medical University Hospital, Taichung
Hospital Clínico Universitario de Valencia, Barcelona
Karmanos Cancer Institute, Detroit
Hôpital C. HURIEZ, Lille
Washington University Medical School, St Louis
Washington University Medical School, St Louis
Washington University Medical School, Creve Coeur
Washington University Medical School, City of Saint Peters
Centre Leon Berard, Lyon
Universitätsklinikum Tübingen, Tübingen
Centro de Alta Especialidad Reumatologia Inv del Potosi SC, San Luis Potosí City
Chang Gung Memorial Hospital - Kaohsiung Branch, Kaohsiung City
The University of Arizona Cancer Center, Tucson
Universitätsklinikum Ulm, Ulm
Universitätsklinikum Erlangen, Erlangen
UCSF Medical Center at Mission Bay, San Francisco
Gustave Roussy, Villejuif
Blokhin Cancer Research Center, Moscow
Arkhangelsk Clinical Oncological Dispensary, Arkhangelsk
Russian Scientific Center of Radiology and Surgical Technologies, Saint Petersburg
Saint-Petersburg City Clinical Oncology Dispensary, Saint Petersburg
Fox Chase Cancer Center, Philadelphia
Hospital de Gastroenterologia Udaondo, Capital Federal
Fundacion Ars Medica, San Salvador de Jujuy
Clinica Viedma, Viedma
Fundación CORI para la Investigación y Prevención del Cáncer, La Rioja
Centro Polivalente de Asistencia e Inv. Clinica CER-San Juan, San Juan
Masarykuv onkologicky ustav, Brno
Fakultni nemocnice Hradec Kralove, Hradec Králové
Fakultni Nemocnice v Motole, Prague
Centre Antoine-Lacassagne, Nice
Arke Estudios Clinicos S.A. de C.V., Mexico City
Asan Medical Center, Seoul
Seoul National University Hospital, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Samsung Medical Center, Seoul
Hospital Duran I Reynals, L'Hospitalet de Llobregat
Hacettepe University Faculty of Medicine, Ankara
Akdeniz University Medical Faculty, Antalya
University College Hospital - London, London
The Christie NHS Foundation Trust, Manchester
Hammersmith Hospital, Acton
The Clatterbridge Cancer Centre, Bebbington
Royal Marsden Hospital, Sutton
Eli Lilly and Company
INDUSTRY